Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Signe Wiese

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 18, 2016
Plasma ADAMTS-13 protein is not associated with portal hypertension or hemodynamic changes in patients with cirrhosisSigne Wiese, Annette Timm, Lars B Nielsen, et al.
European Journal of Gastroenterology & Hepatology|December 12, 2017
Total bile acid levels are associated with left atrial volume and cardiac output in patients with cirrhosisAndrei M Voiosu, Signe Wiese, Theodor A Voiosu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 10, 2013
Cardiac and proinflammatory markers predict prognosis in cirrhosisSigne Wiese, Christian Mortensen, Jens P Gøtze, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|December 29, 2021
Dipeptidyl peptidase-3 is associated with severity of liver disease and circulatory complications in patients with cirrhosisAndrei Mihai Voiosu, Signe Wiese, Jens Peter Goetze, et al.
Biomarkers in Medicine|October 9, 2023
Peptidylglycine α-amidating monooxygenase and adrenomedullin measurement in patients with hepatic cirrhosisJens P Goetze, Andrei Voiosu, Signe Wiese, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|December 17, 2019
Dobutamine reverses the cardio-suppressive effects of terlipressin without improving renal function in cirrhosis and ascites: a randomized controlled trialMads Israelsen, Emilie Kristine Dahl, Bjørn Stæhr Madsen, et al.
The American Journal of Gastroenterology|August 2, 2022
Cardiovascular Mapping in Cirrhosis From the Compensated Stage to Hepatorenal Syndrome: A Magnetic Resonance StudyKaren Vagner Danielsen, Signe Wiese, Troels Busk, et al.
Alimentary Pharmacology & Therapeutics|April 26, 2023
Altered serum bile acid composition is associated with cardiac dysfunction in cirrhosisSigne Wiese, Karen V Danielsen, Troels Busk, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|June 20, 2019
Cardiac dysfunction in cirrhosis: a 2-yr longitudinal follow-up study using advanced cardiac imagingSigne Wiese, Jens D Hove, Silje Mo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 2, 2018
Myocardial extracellular volume quantified by magnetic resonance is increased in cirrhosis and related to poor outcomeSigne Wiese, Jens Hove, Silje Mo, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 18, 2016
Plasma ADAMTS-13 protein is not associated with portal hypertension or hemodynamic changes in patients with cirrhosisSigne Wiese, Annette Timm, Lars B Nielsen, et al.
European Journal of Gastroenterology & Hepatology|December 12, 2017
Total bile acid levels are associated with left atrial volume and cardiac output in patients with cirrhosisAndrei M Voiosu, Signe Wiese, Theodor A Voiosu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 10, 2013
Cardiac and proinflammatory markers predict prognosis in cirrhosisSigne Wiese, Christian Mortensen, Jens P Gøtze, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|December 29, 2021
Dipeptidyl peptidase-3 is associated with severity of liver disease and circulatory complications in patients with cirrhosisAndrei Mihai Voiosu, Signe Wiese, Jens Peter Goetze, et al.
Biomarkers in Medicine|October 9, 2023
Peptidylglycine α-amidating monooxygenase and adrenomedullin measurement in patients with hepatic cirrhosisJens P Goetze, Andrei Voiosu, Signe Wiese, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|December 17, 2019
Dobutamine reverses the cardio-suppressive effects of terlipressin without improving renal function in cirrhosis and ascites: a randomized controlled trialMads Israelsen, Emilie Kristine Dahl, Bjørn Stæhr Madsen, et al.
The American Journal of Gastroenterology|August 2, 2022
Cardiovascular Mapping in Cirrhosis From the Compensated Stage to Hepatorenal Syndrome: A Magnetic Resonance StudyKaren Vagner Danielsen, Signe Wiese, Troels Busk, et al.
Alimentary Pharmacology & Therapeutics|April 26, 2023
Altered serum bile acid composition is associated with cardiac dysfunction in cirrhosisSigne Wiese, Karen V Danielsen, Troels Busk, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|June 20, 2019
Cardiac dysfunction in cirrhosis: a 2-yr longitudinal follow-up study using advanced cardiac imagingSigne Wiese, Jens D Hove, Silje Mo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 2, 2018
Myocardial extracellular volume quantified by magnetic resonance is increased in cirrhosis and related to poor outcomeSigne Wiese, Jens Hove, Silje Mo, et al.
Pageof 3